↓ Skip to main content

DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities

Overview of attention for article published in International Journal of Clinical Pharmacy, January 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#4 of 1,599)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
3 news outlets
blogs
1 blog
twitter
172 X users
facebook
1 Facebook page

Citations

dimensions_citation
76 Dimensions

Readers on

mendeley
201 Mendeley
Title
DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities
Published in
International Journal of Clinical Pharmacy, January 2019
DOI 10.1007/s11096-019-00784-9
Pubmed ID
Authors

Nagham Ailabouni, Dee Mangin, Prasad S. Nishtala

X Demographics

X Demographics

The data shown below were collected from the profiles of 172 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 201 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 201 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 12%
Student > Ph. D. Student 23 11%
Researcher 16 8%
Student > Doctoral Student 15 7%
Student > Bachelor 14 7%
Other 37 18%
Unknown 72 36%
Readers by discipline Count As %
Medicine and Dentistry 39 19%
Pharmacology, Toxicology and Pharmaceutical Science 27 13%
Nursing and Health Professions 19 9%
Social Sciences 9 4%
Psychology 8 4%
Other 20 10%
Unknown 79 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 140. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2023.
All research outputs
#300,887
of 25,692,343 outputs
Outputs from International Journal of Clinical Pharmacy
#4
of 1,599 outputs
Outputs of similar age
#6,612
of 449,351 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#1
of 16 outputs
Altmetric has tracked 25,692,343 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,599 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,351 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.